Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05914766 · ClinicalTrials.gov registry record · NA
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
A NA study of Rectal Cancer and Self Efficacy, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT05914766: Recruiting NA study of Rectal Cancer and Self Efficacy, sponsored by Massachusetts General Hospital.
NCT05914766 is a NA study of Rectal Cancer and Self Efficacy that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05914766, a NA study of Rectal Cancer and Self Efficacy, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.
Primary Outcome
The primary outcome will be feasibility, defined as ≥60% retention of participants over the four-week intervention.
Conditions Studied
Interventions
- OTHER Enhanced usual care
- BEHAVIORAL PATHWAYS
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT05914766 shows while recruiting
NCT05914766 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Rectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Enhanced usual care is the first listed.
NCT05914766 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05914766 about?
NCT05914766 is a clinical study titled "An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer". The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.
What is the current status of trial NCT05914766?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-09-21. Estimated completion is 2028-12.
What conditions does trial NCT05914766 study?
This clinical trial studies the following conditions: Rectal Cancer, Self Efficacy.
What interventions are being tested in trial NCT05914766?
The interventions under investigation include: Enhanced usual care (OTHER), PATHWAYS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05914766?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05914766 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05914766's enrollment target sits among peer trials
80 30th of 70 higher than 41 of 70 other Rectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy